UPDATE 2-Argenx's Vyvgart sales jump in second quarter, shares climb

(Adds share move in para 1 and 3, adds broker comments in paragraph 4, adds CFO comments in paragraph 7-8 and 10-12) By Lucie Barbier July 23 (Reuters) – Belgian-Dutch immunology company argenx said

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)